Hanson McClain Advisors »

Lexicon Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $631 263 2.40

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Series Trust ST STR P500GRW (SPYG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Spdr Series Trust St Str P500val (SPYV)
Apple Call Call Option (Principal) (AAPL)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds St Port Mark Etf (SPEM)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Mbs Etf (MBB)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)

View all positions for Hanson McClain Advisors

Top funds holding Lexicon Pharmaceuticals

Artal Group
FMR
Siren
Sessa Capital IM
BlackRock
Vanguard Capital Management
Point72 Asset Management
Geode Capital Management
Vanguard Portfolio Management
Citadel Advisors
Northern Trust
Charles Schwab Investment Management
Sixth Street Partners Management Company
Vanguard Fiduciary Trust
Susquehanna International

View all funds holding Lexicon Pharmaceuticals